| 摘要 |
PROBLEM TO BE SOLVED: To provide a composition that improves pharmacokinetic characteristics of a therapeutic component. SOLUTION: There is provided a composition, including a therapeutic component and an efficacy enhancing component, that improves pharmacokinetic characteristics of the therapeutic component. The therapeutic component may includeα-2-adrenergic agonist, and the efficacy enhancing component may include a fatty acid. In one embodiment, the therapeutic component and the efficacy enhancing component form a complex. The efficacy enhancing component is selected from the group consisting of anionic polymers, saturated fatty acids, unsaturated fatty acids and mixtures thereof. Specifically, the efficacy enhancing component is linolenic acid, and the therapeutic component is brimonidine. COPYRIGHT: (C)2010,JPO&INPIT
|
